NM_021098.3:c.4608C>A
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP7
The NM_021098.3(CACNA1H):c.4608C>A(p.Ile1536Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. I1536I) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.4644C>A | p.Ile1548Ile | synonymous_variant | Exon 25 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000564231.6 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.4569C>A | p.Ile1523Ile | synonymous_variant | Exon 25 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.4569C>A | p.Ile1523Ile | synonymous_variant | Exon 25 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.4608C>A | p.Ile1536Ile | synonymous_variant | Exon 25 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*578C>A | non_coding_transcript_exon_variant | Exon 25 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000711448.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.4608C>A | non_coding_transcript_exon_variant | Exon 25 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*578C>A | 3_prime_UTR_variant | Exon 25 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000711450.1 | c.4567-21C>A | intron_variant | Intron 24 of 34 | ENSP00000518762.1 | |||||
| CACNA1H | ENST00000639478.1 | n.4567-21C>A | intron_variant | Intron 24 of 34 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2480-21C>A | intron_variant | Intron 24 of 34 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4014-21C>A | intron_variant | Intron 23 of 33 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461192Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 726900 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change affects codon 1536 of the CACNA1H mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CACNA1H protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at